Komori
Medikit (7749) · TargetAdvanced

Enhancement of Component Production Capacity at the Hyuga Plant and Hyuga No. 2 Plant

First written in FY2016. 7 of 10 entries say "Advanced", first in FY2018. Latest entry: FY2026.

10entries
11years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2016 – FY2017AdvancedFY2018AdvancedFY2021 – FY20262016: 120162017: 120172018: 120182019: 020192020: 120202021: 120212022: 120222023: 120232024: 120242025: 120252026: 12026
Same theme, other companies
Expansion and Rationalization of Manufacturing FacilitiesA theme 446 companies write about · 0 as a headwind · 486 as a tailwind
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 183 companies compared. The sentences above are computed from all 183.Comparing 200 of the theme's 486 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「東郷メディキット㈱ Hyuga Plant Medical device production equipment ¥183.5 million ¥84.15 million Internal funds April 2025 March 2027 Expansion of product production capacity 東郷メディキット㈱ Hyuga No. 2 Plant Medical device production equipment ¥1,248.9 million ¥278.062 million Internal funds December 2024 January 2027 Expansion of component production capacity 東郷メディキット㈱ Hyuga No. 3 Plant Medical device production equipment ¥85 million ¥28.3 million Internal funds April 2025 May 2026 Expansion of shipping and packaging equipment」

    The plan was updated for the Hyuga Plant, Hyuga No. 2 Plant and Hyuga No. 3 Plant to expand product and component production capacity and shipping and packaging equipment, with completion scheduled in 2026–2027.
  2. FY2025AdvancedAnnual report

    「Property, plant and equipment increased by ¥2,973.778 million, or 25.9%, to ¥14,447.94 million, mainly due to the expansion of the Hyuga No. 2 Plant and construction of the Hyuga No. 3 Plant.」

    The expansion of the Hyuga No. 2 Plant and construction of the Hyuga No. 3 Plant, among other factors, were reflected in the property, plant and equipment balance, which increased by ¥2,973.778 million, or 25.9%, from the end of the previous fiscal year.
  3. FY2025-H1AdvancedAnnual report

    「Property, plant and equipment increased by ¥1,820.201 million, or 15.9%, to ¥13,294.364 million, mainly due to the expansion of the Hyuga No. 2 Plant and construction of the Hyuga No. 3 Plant.」

    Property, plant and equipment increased by ¥1,820.201 million, or 15.9%, due mainly to the expansion of the Hyuga No. 2 Plant and construction of the Hyuga No. 3 Plant. The facility expansions are reflected in the asset balance.
  4. FY2023AdvancedAnnual report

    「東郷メディキット㈱ Hyuga Plant Medical device production equipment ¥71.25 million Internal funds May 2023 March 2024 Expansion of product production capacity 東郷メディキット㈱ Hyuga No. 2 Plant Medical device production equipment ¥1,328 million Internal funds January 2023 April 2024 Building extension 東郷メディキット㈱ Hyuga No. 3 Plant Medical device production equipment ¥1,704.6 million Internal funds April 2023 August 2024 Installation of an automated warehouse」

    For the Hyuga Plant, Hyuga No. 2 Plant and Hyuga No. 3 Plant, the facility plan was updated to approximately ¥3.56 billion in internal funds, covering expansion of product and component production capacity, building extensions and installation of automated warehouses, with completion scheduled from 2023 to 2024.
  5. FY2022AdvancedAnnual report

    「東郷メディキット㈱ Hyuga Plant Medical device production equipment ¥147.5 million Internal funds January 2022 December 2022 Expansion of product production capacity 東郷メディキット㈱ Hyuga No. 2 Plant Medical device production equipment ¥212 million Internal funds December 2021 April 2023 Expansion of product production capacity 東郷メディキット㈱ Hyuga No. 3 Plant Medical device production equipment ¥1,380 million ¥1.2 million Internal funds June 2022 March 2024 Installation of an automated warehouse」

    The facility plan was updated to include production capacity expansions at the Hyuga Plant and Hyuga No. 2 Plant and installation of an automated warehouse at the Hyuga No. 3 Plant, with scheduled completion dates.
  6. FY2021AdvancedAnnual report

    「東郷メディキット㈱ Hyuga Plant Medical device production equipment ¥320 million — Internal funds April 2021 March 2022 Expansion of product production capacity 東郷メディキット㈱ Hyuga Plant Medical device production equipment ¥629.3 million ¥22.3 million Internal funds April 2021 March 2022 Expansion of component production capacity 東郷メディキット㈱ Hyuga No. 2 Plant Medical device production equipment ¥1,430 million — Internal funds July 2021 March 2022 Installation of an automated warehouse 東郷メディキット㈱ Hyuga No. 3 Plant Medical device production equipment ¥1,353.9 million ¥205.05 million Internal funds April 2021 December 2021 Installation of a sterilization facility」

    The plan was updated to a total of ¥3,893 million, including the installation of a sterilization facility at the Hyuga No. 3 Plant in addition to capacity expansions at the Hyuga Plant and Hyuga No. 2 Plant. The filing states that the production building at the Hyuga Plant is operating after its construction.
  7. FY2020Updated plan to install production equipment and an automated warehouseAnnual report

    「東郷メディキット㈱ Hyuga Plant Medical device production equipment ¥892.1 million ¥10.35 million Internal funds December 2019 March 2021 Expansion of product production capacity 東郷メディキット㈱ Hyuga No. 2 Plant Medical device production equipment ¥1,430 million — Internal funds July 2020 March 2021 Installation of an automated warehouse 東郷メディキット㈱ Hyuga No. 2 Plant Medical device production equipment ¥500 million — Internal funds March 2020 December 2020 Expansion of product production capacity」

    The facility plan was updated to include expansion of product and component production capacity and installation of an automated warehouse at the Hyuga Plant and Hyuga No. 2 Plant, with scheduled completion dates.
  8. FY2018AdvancedAnnual report

    「東郷メディキット㈱ Hyuga Plant Medical device production equipment ¥1,415.6 million ¥301.021 million Internal funds August 2017 March 2019 Expansion of product production capacity 東郷メディキット㈱ Hyuga Plant Medical device production equipment ¥210.663 million — Internal funds January 2018 March 2019 Expansion of component production capacity 東郷メディキット㈱ Hyuga No. 2 Plant Medical device production equipment ¥183.8 million ¥53.645 million Internal funds January 2018 October 2018 Expansion of component production capacity」

    The plan for production capacity expansion at the Hyuga Plant and Hyuga No. 2 Plant was updated to a total of ¥1,810.063 million in internal funds, including amounts already paid.
  9. FY2017Updated plan for the next expansion of production facilitiesAnnual report

    「東郷メディキット㈱ Hyuga Plant Medical device production equipment ¥308.3 million Internal funds April 2017 November 2017 Expansion of product production capacity 東郷メディキット㈱ Hyuga No. 2 Plant Medical device production equipment ¥423.2 million Internal funds April 2017 March 2018 Expansion of component production capacity」

    A next-stage production capacity expansion plan funded with internal funds, totaling ¥731.5 million, was presented for the Hyuga Plant and Hyuga No. 2 Plant.
  10. FY2016First statedAnnual report

    「At the Hyuga Plant, the company plans to invest ¥217.18 million, with work starting in July 2015 and scheduled for completion in January 2017, to expand component production capacity. At the Hyuga No. 2 Plant, the company plans to invest ¥558.1 million, with work starting in December 2015 and scheduled for completion in November 2016, to expand component production capacity.」

    Specific investment amounts, scheduled start and completion dates, and the capacity to be expanded are provided for the 2 plants.
Moved together

"Retained Earnings for Stable Dividends, Development and Investment" moved the same way as this thread, in the same document, in 5 of its 10 moves.

555544★123456
  1. ★This thread
  2. 1Retained Earnings for Stable Dividends, Development and Investment5×
  3. 2Launch and Improvement of Products with Safety Mechanisms and New Catheter Products5×
  4. 3Obtaining Overseas Certifications and Expanding into the US and European Markets5×
  5. 4Holding of 962,200 treasury shares5×
  6. 5Establishing a Framework for Global Business Expansion4×
  7. 6Strengthening production capabilities through a division of roles between domestic and Vietnam sites4×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Medikit's next results are scheduled for 2026-11-12. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.